<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="pmc">PeerJ</journal-id>
      <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
      <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
      <journal-title-group>
        <journal-title>PeerJ</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2167-8359</issn>
      <publisher>
        <publisher-name>PeerJ Inc.</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">48</article-id>
      <article-id pub-id-type="doi">10.7717/peerj.48</article-id>
      <article-categories>
        <subj-group subj-group-type="categories">
          <subject>Biochemistry</subject>
          <subject>Cardiology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A non-cardiomyocyte autonomous mechanism of cardioprotection involving the SLO1 BK channel</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib id="author-1" contrib-type="author">
          <name>
            <surname>Wojtovich</surname>
            <given-names>Andrew P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-2" contrib-type="author">
          <name>
            <surname>Nadtochiy</surname>
            <given-names>Sergiy M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-3" contrib-type="author">
          <name>
            <surname>Urciuoli</surname>
            <given-names>William R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-4" contrib-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>Charles O.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-3">3</xref>
        </contrib>
        <contrib id="author-5" contrib-type="author">
          <name>
            <surname>Grunnet</surname>
            <given-names>Morten</given-names>
          </name>
          <xref ref-type="aff" rid="aff-4">4</xref>
          <xref ref-type="aff" rid="aff-5">5</xref>
        </contrib>
        <contrib id="author-6" contrib-type="author">
          <name>
            <surname>Nehrke</surname>
            <given-names>Keith</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-7" contrib-type="author" corresp="yes">
          <name>
            <surname>Brookes</surname>
            <given-names>Paul S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
          <email>paul_brookes@urmc.rochester.edu</email>
        </contrib>
        <aff id="aff-1"><label>1</label><institution>Department of Medicine, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>USA</country></aff>
        <aff id="aff-2"><label>2</label><institution>Department of Anesthesiology, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>USA</country></aff>
        <aff id="aff-3"><label>3</label><institution>Department of Biochemistry, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>USA</country></aff>
        <aff id="aff-4"><label>4</label><institution>Lundbeck AS</institution>, <addr-line>Valby</addr-line>, <country>Denmark</country></aff>
        <aff id="aff-5"><label>5</label><institution>Acesion Pharma</institution>, <addr-line>Copenhagen</addr-line>, <country>Denmark</country></aff>
      </contrib-group>
      <contrib-group content-type="editors">
        <contrib id="editor-1" contrib-type="editor">
          <name>
            <surname>Xie</surname>
            <given-names>Lai-Hua</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2013-03-05">
        <day>5</day>
        <month>3</month>
        <year iso-8601-date="2013">2013</year>
      </pub-date>
      <volume>1</volume>
      <elocation-id>e48</elocation-id>
      <history>
        <date date-type="received" iso-8601-date="2013-01-03">
          <day>3</day>
          <month>1</month>
          <year iso-8601-date="2013">2013</year>
        </date>
        <date date-type="accepted" iso-8601-date="2013-02-19">
          <day>19</day>
          <month>2</month>
          <year iso-8601-date="2013">2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2013 Wojtovich et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Wojtovich et al.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://peerj.com/articles/48"/>
      <abstract>
        <p>Opening of BK-type <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content> activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels protects the heart against ischemia-reperfusion (IR) injury. However, the location of BK channels responsible for cardioprotection is debated. Herein we confirmed that openers of the SLO1 BK channel, NS1619 and NS11021, were protective in a mouse perfused heart model of IR injury. As anticipated, deletion of the <italic>Slo1</italic> gene blocked this protection. However, in an isolated cardiomyocyte model of IR injury, protection by NS1619 and NS11021 was insensitive to <italic>Slo1</italic> deletion. These data suggest that protection in intact hearts occurs by a non-cardiomyocyte autonomous, SLO1-dependent, mechanism. In this regard, an <italic>in-situ</italic> assay of intrinsic cardiac neuronal function (tachycardic response to nicotine) revealed that NS1619 preserved cardiac neurons following IR injury. Furthermore, blockade of synaptic transmission by hexamethonium suppressed cardioprotection by NS1619 in intact hearts. These results suggest that opening SLO1 protects the heart during IR injury, via a mechanism that involves intrinsic cardiac neurons. Cardiac neuronal ion channels may be useful therapeutic targets for eliciting cardioprotection.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Large conductance potassium channel</kwd>
        <kwd>Ischemia</kwd>
        <kwd>Reperfusion</kwd>
        <kwd>Preconditioning</kwd>
        <kwd>Cardiac neurons</kwd>
        <kwd>NS1619</kwd>
        <kwd>NS11021</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="fund-1">
          <funding-source>National Institutes of Health</funding-source>
          <award-id>RO1-HL071158</award-id>
          <award-id>RO1-GM087483</award-id>
        </award-group>
        <award-group id="fund-2">
          <funding-source>American Heart Association</funding-source>
          <award-id>11POST7290028</award-id>
        </award-group>
        <funding-statement>Work was funded by grants from the US National Institutes of Health, HL071158 (to PSB) and GM087483 (to PSB &amp; KWN). APW is funded by an American Heart Association Founder’s Affiliate Postdoctoral Fellowship award (11POST7290028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>All tissues, including the heart, possess endogenous mechanisms to protect against ischemia-reperfusion (IR) injury, and the opening of <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels is central to many cardioprotective paradigms including ischemic preconditioning (IPC) and anesthetic preconditioning (APC) (<xref ref-type="bibr" rid="ref-21">Facundo, Fornazari &amp; Kowaltowski, 2006</xref>). The mitochondrial K<sub>ATP</sub> channel is perhaps the most widely associated with cardioprotection (<xref ref-type="bibr" rid="ref-44">O’Rourke, 2007</xref>; <xref ref-type="bibr" rid="ref-69">Zoratti et al., 2009</xref>), but a large-conductance (BK) channel encoded by the <italic>Slo</italic> gene family is also proposed to play a protective role in the heart  (<xref ref-type="bibr" rid="ref-14">Bentzen et al., 2009</xref>; <xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>). The <italic>Slo</italic> encoded channels comprise 3 isoforms (SLO1/ 2/3) (<xref ref-type="bibr" rid="ref-51">Salkoff et al., 2006</xref>), and although a channel resembling SLO1 (<named-content content-type="chemical-compound">K<sub>Ca</sub>1.1</named-content>, KCNMA1) has been reported in mitochondria (<xref ref-type="bibr" rid="ref-53">Siemen et al., 1999</xref>), gene deletion experiments show that <italic>Slo1</italic> is not required for cardioprotection by IPC or APC (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>).</p>
      <p>Despite ongoing debate regarding the identity of a mitochondrial BK channel, it is widely reported that SLO1 is expressed in the heart (<xref ref-type="bibr" rid="ref-18">Chen et al., 2005</xref>; <xref ref-type="bibr" rid="ref-33">Jiang et al., 1999</xref>; <xref ref-type="bibr" rid="ref-57">Tseng-Crank et al., 1994</xref>). Furthermore, SLO1 activation by small molecules such as NS1619 and NS11021 is cardioprotective (<xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>; <xref ref-type="bibr" rid="ref-13">Bentzen et al., 2007</xref>). SLO1 is not found at the cardiomyocyte plasma membrane (<xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>), but SLO1 channel activity has been reported in intra-cardiac neurons (<xref ref-type="bibr" rid="ref-23">Franciolini et al., 2001</xref>) and Purkinje fibers (<xref ref-type="bibr" rid="ref-15">Callewaert, Vereecke &amp; Carmeliet, 1986</xref>), where it is thought to play a role in regulating heart rate (<xref ref-type="bibr" rid="ref-32">Imlach et al., 2010</xref>).</p>
      <p>Despite the assumption that NS1619 and NS11021 protect via a (mitochondrial) SLO1 (<xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>), many non-specific effects such as opening of other ion channels (<xref ref-type="bibr" rid="ref-46">Park et al., 2007</xref>; <xref ref-type="bibr" rid="ref-50">Saleh et al., 2007</xref>; <xref ref-type="bibr" rid="ref-30">Holland et al., 1996</xref>) and inhibition of mitochondrial function (<xref ref-type="bibr" rid="ref-1">Aldakkak et al., 2010</xref>; <xref ref-type="bibr" rid="ref-2">Aon et al., 2010</xref>; <xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>; <xref ref-type="bibr" rid="ref-20">Debska et al., 2003</xref>; <xref ref-type="bibr" rid="ref-35">Kicinska &amp; Szewczyk, 2004</xref>) have been reported for these compounds, and a pharmaco-genomic study has not been conducted. Such SLO1-independent effects could underlie the cardioprotective benefit of these compounds (<xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>; <xref ref-type="bibr" rid="ref-35">Kicinska &amp; Szewczyk, 2004</xref>), and herein we sought to investigate the contribution of SLO1 to the cardioprotection elicited by NS1619 and NS11021, including studies in <italic>Slo1</italic><sup>−/−</sup> mice to control for off-target effects. We report on the discovery of a non-cardiomyocyte autonomous mechanism of cardioprotection involving SLO1 and intrinsic cardiac neurons.</p>
    </sec>
    <sec>
      <title>Materials &amp; Methods</title>
      <sec>
        <title>Reagents, animals</title>
        <p>NS11021 was a gift from Neurosearch A/S (Ballerup, Denmark). All other chemicals were of the highest grade available from Sigma (St. Louis, MO) unless otherwise specified. <italic>Slo1</italic><sup>−/−</sup> (KCNMA1<sup>−/−</sup>) mice were generated on the FVB background via deletion of Exon1, which contains the translation start site and the S0 trans-membrane segment (<xref ref-type="bibr" rid="ref-38">Meredith et al., 2004</xref>). This results in both transcripts and protein being undetectable, and it has been previously shown that the lack of an S0 domain results in a nonfunctional BK channel  (<xref ref-type="bibr" rid="ref-68">Zarei et al., 2001</xref>; <xref ref-type="bibr" rid="ref-67">Zarei et al., 2004</xref>). Animals were genotyped by tail biopsy PCR, as previously described (<xref ref-type="bibr" rid="ref-38">Meredith et al., 2004</xref>). All experiments used male WT and <italic>Slo1</italic><sup>−/−</sup> littermates age 6–8 weeks. Mice were maintained in an AAALAC-accredited pathogen-free barrier facility with food and water available <italic>ad libitum</italic>. All procedures were in accordance with the NIH <italic>Guide for the Care and Use of Laboratory Animals</italic> (2011 revision) and were approved by the University Committee on Animal Resources.</p>
      </sec>
      <sec>
        <title>Mouse Langendorff <italic>ex-vivo</italic> perfused heart</title>
        <p>Following avertin anesthesia, a thoracotomy was performed, the aorta cannulated <italic>in-situ</italic> and the heart rapidly transferred to perfusion apparatus as previously described (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>; <xref ref-type="bibr" rid="ref-41">Nadtochiy et al., 2009</xref>). The heart was perfused with Krebs-Henseleit buffer in constant flow mode (4 ml/min). The following experimental protocols were observed: (i) IR injury: 20 min normoxic perfusion, 40 min global ischemia, 60 min reperfusion. (ii) NS1619+IR: 10 min normoxic perfusion, 10 min of 5 µM NS1619, 30 s washout, then IR as above. (iii) NS11021+IR: 10 min normoxic perfusion, 10 min of 500 nM NS11021, 30 s washout, then IR as above.</p>
        <p>Studies involving hexamethonium were independently controlled and the following experimental protocols were observed: (iv) IR injury: 25 min normoxic perfusion, 35 min global ischemia, 60 min reperfusion. (v) NS1619+IR: 15 min normoxic perfusion, 10 min of 5 µM NS1619, 30 s washout, then IR as above. (vi) NS1619+IR+Hexamethonium: 12.5 min normoxic perfusion, 2.5 min of 500 µM hexamethonium, 10 min of 5 µM NS1619 plus 500 µM hexamethonium, 30 s washout of NS1619 only, 35 min global ischemia, 5 min reperfusion plus 500 µM hexamethonium, 55 min reperfusion. (vii) Atpenin A5 (AA5)+IR: 5 min normoxic perfusion, 20 min of 10 nM AA5, 30 s washout, then IR as above. (viii) AA5+IR+Hexamethonium: 2.5 min normoxic perfusion, 2.5 min of 500 µM hexamethonium, 20 min of 10 nM AA5 plus 500 µM hexamethonium, 30 s washout of AA5 only, 35 min global ischemia, 5 min reperfusion plus 500 µM hexamethonium, 55 min reperfusion. Note that different ischemic times (35 vs. 40 min) were used to ensure adequate independent controls for every group examined.</p>
        <p>To assess neuronal survival, hearts were exposed to 100 µM nicotine for 5 min following the reperfusion period. Compounds were delivered via a syringe pump linked to an injection port immediately above the perfusion cannula. The volume of added solutions was ≤0.05% of the total perfusate volume. Following experimental protocols, hearts were TTC stained and imaged as previously described to quantify infarct size (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>; <xref ref-type="bibr" rid="ref-42">Nadtochiy et al., 2011</xref>).</p>
      </sec>
      <sec>
        <title>Mouse cardiomyocyte isolation</title>
        <p>Following avertin anesthesia, the aorta was cannulated <italic>in-situ</italic> and the heart rapidly transferred to perfusion apparatus. The heart was perfused for 3 min with a modified Krebs-Henseleit “buffer A” (118 mM NaCl, 4.7 mM KCl, 1.2 mM <named-content content-type="chemical-compound">KH<sub>2</sub>PO<sub>4</sub></named-content>, 1.2 mM <named-content content-type="chemical-compound">MgSO<sub>4</sub></named-content>, 10 mM HEPES, 24 mM <named-content content-type="chemical-compound">NaHCO<sub>3</sub></named-content>, 5.5 mM glucose, bubbled with 95% <named-content content-type="chemical-compound">O<sub>2</sub></named-content>, 5% <named-content content-type="chemical-compound">CO<sub>2</sub></named-content>, pH 7.35, 37 °C) at 3 ml/min to remove blood. The heart was then perfused with digestion buffer (buffer A plus 0.25 mM <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content>, 30 mM taurine, 10 mM 2,3-butanedione monoxime, 0.0278% Trypsin, 25 mg collagenase A, 75 mg collagenase D) at 3 ml/min for 12 min. The heart was removed and teased apart with forceps. Tissue was dispersed with 10 ml stop buffer (buffer A plus 12.5 µM <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content>, 10% FBS) with a transfer pipette, then passed through a 200 µm filter. Myocytes were settled by gravity for 10 min, supernatant removed, and pellet resuspended in 10 ml stop buffer. <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>was gradually increased from 12.5 µM to 0.25 mM through four additions of <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content> over the course of 8 min. Myocytes were settled by gravity for 10 min, supernatant removed, and pellet resuspended in 5 ml normoxic buffer (buffer A plus 0.25 mM <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content>, 10% FBS). Myocytes were counted and viability determined by Trypan blue exclusion. One mouse heart typically yielded 1.2 × 10<sup>6</sup> cells (75% viable) and cells were used for simulated IR injury immediately after isolation.</p>
      </sec>
      <sec>
        <title>Mouse cardiomyocyte simulated IR injury</title>
        <p>Myocytes were equilibrated at a concentration of 10<sup>5</sup> cells/ml for 10 min in normoxic buffer. Incubations were in 50 ml round-bottom tubes in a shaking water bath (80 cycles/min) at 37 °C. Myocytes were divided in to the following groups (i) Control, 100 min in normoxic buffer; (ii) Simulated ischemia-reperfusion (SIR), 10 min normoxic buffer, then 1 h ischemia buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM <named-content content-type="chemical-compound">KH<sub>2</sub>PO<sub>4</sub></named-content>, 1.2 mM <named-content content-type="chemical-compound">MgSO<sub>4</sub></named-content>, 10 mM HEPES, 24 mM <named-content content-type="chemical-compound">NaHCO<sub>3</sub></named-content>, 0.25 mM <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content>, 10% FBS, gassed with 95% <named-content content-type="chemical-compound">N<sub>2</sub></named-content>, 5% <named-content content-type="chemical-compound">CO<sub>2</sub></named-content>, pH 6.5, 37 °C), followed by 30 min normoxic buffer; (iii) Drug + SIR, comprising treatment with compounds 10 min prior to SIR in normoxic buffer, then 1 h ischemia buffer, 30 min normoxic buffer. Drugs tested (final concentrations in parentheses) were: NS1619 (5 µM), NS11021 (500 nM) and diazoxide (10 µM). Drugs were dissolved in DMSO and the vehicle comprised &lt;0.1% of total incubation volume. DMSO was included in the control and SIR groups at the appropriate times. To change buffers, cells were centrifuged at 31 × <italic>g</italic> for 2 min, and the pellet resuspended in the appropriate buffer. At the end of protocols, viability was determined by Trypan blue exclusion.</p>
      </sec>
      <sec>
        <title>Isolated mitochondrial BK channel activity</title>
        <p>Mitochondria were isolated from 3 mouse hearts as previously described  (<xref ref-type="bibr" rid="ref-64">Wojtovich et al., 2010</xref>). The mitochondria were incubated with 20 µM BTC-AM and 0.05% Pluronic F-127 for 10 min at room temperature. The final mitochondrial pellet was suspended in 225 µl and stored on ice until use, within 1.5 h <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content> uptake into mitochondria was measured using a Varian Cary Eclipse spectrofluorimeter as previously described (<xref ref-type="bibr" rid="ref-64">Wojtovich et al., 2010</xref>) by monitoring changes in BTC fluorescence (λ<sub>EX</sub> 488 nm, λ<sub>EM</sub> 525 nm). Where indicated, ATP (to block mK<sub>ATP</sub> channel), NS compounds (to open mBK channels) and paxilline (to block BK channels) were present at concentrations indicated.</p>
      </sec>
      <sec>
        <title>Total heart histochemical acetylcholinesterase staining</title>
        <p>Following IR protocols as described above, hearts were perfused with 10 mM phosphate buffered saline (PBS; pH 7.4 at 25 °C) for 3 min at 4 ml/min. Control hearts not exposed to IR injury were cannulated and perfused with PBS. Hearts were then stained for acetylcholinesterase (<xref ref-type="bibr" rid="ref-49">Rysevaite et al., 2011</xref>). Hearts were prefixed with 4% formalin for 30 min at 4 °C, then washed with PBS and incubated in PBS supplemented with hyaluronidase (0.5 mg/100 ml) for 18 h at 4 °C. The hearts were then placed in Karnovsky-Roots medium (60 mM sodium acetate, 2 mM acetylthiocholine iodide, 15 mM sodium citrate, 3 mM <named-content content-type="chemical-compound">CuSO<sub>4</sub></named-content>, 0.5 mM <named-content content-type="chemical-compound">K<sub>3</sub>Fe(CN)<sub>6</sub></named-content>, 0.1% trition-X 100, 0.5 mg/100 ml hyaluronidase, pH 5.6 at 4 °C) for 3 h at 4 °C. Following staining, hearts were kept in 10% formalin and visualized under fluorescent illumination using GFP filters on an Olympus MVX wide field dissecting microscope. Images were obtained using a PixeLink camera. The fluorescent illumination provided increased contrast compared to visible light with the monochrome CCD.</p>
      </sec>
      <sec>
        <title>Statistics</title>
        <p>Data presented are means ± SEM. Statistical significance (<italic>p</italic> &lt; 0.05) between multiple groups was determined using analysis of variance (ANOVA) with Bonferroni correction. Mixed effects models were generated using “R” software (R Development Core Team) and the R packages lme4 (<xref ref-type="bibr" rid="ref-10">Bates &amp; Maechler, 2009</xref>) and languageR (<xref ref-type="bibr" rid="ref-8">Baayen, 2008</xref>; <xref ref-type="bibr" rid="ref-9">Baayen, 2009</xref>). As fixed effects, we included treatment conditions, genotype, and their interaction in the model. Normality and homogeneity were checked using visual inspections of plots of residuals against fitted values. Likelihood ratio tests comparing the models with fixed effects to the null models using only random effects, were used to assess the accuracy of the mixed effects models. The model was further analyzed using pair wise comparison <italic>t</italic>-test. We rejected results where the model including fixed effects did not differ significantly from the null model. For all mixed effects models we present MCMC-estimated <italic>p</italic>-values that are considered significant at the α &lt; 0.05 level.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Protection of intact hearts by NS1619 and NS11021 requires Slo1</title>
        <p>Previously we showed that cardioprotection by both IPC and APC in intact hearts is SLO1 independent (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>). However, the SLO1 openers NS1619 and NS11021 are still reported to protect against IR injury in intact hearts  (<xref ref-type="bibr" rid="ref-14">Bentzen et al., 2009</xref>; <xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>), suggesting that SLO1 alone can afford protection. To examine the pharmaco-genomics of SLO1, NS1619 and NS11021 in more detail, we utilized an <italic>ex-vivo</italic> perfused heart model of IR injury. Representative raw data tracings of cardiac function during IR injury are shown in <xref ref-type="fig" rid="fig-1">Fig. 1</xref>. Hearts from WT and <italic>Slo1</italic><sup>−/−</sup> mice exhibited similar sensitivity to IR (quantitative data shown in <xref ref-type="fig" rid="fig-2">Fig. 2</xref>), and as previously reported both NS1619 and NS11021 protected the WT heart from IR injury (enhanced functional recovery and reduced infarct size), with NS11021 being 10-fold more potent than NS1619. As anticipated, protection was lost in <italic>Slo1</italic><sup>−/−</sup> hearts, suggesting that SLO1 is a <italic>bona-fide</italic> target for the cardioprotective effects of NS1619 and NS11021 in the intact heart. While it is possible that SLO1 is merely a downstream mediator of protection by NS1619 and NS11021, Occam’s razor would suggest SLO1 is the actual target.</p>
        <fig id="fig-1">
          <object-id pub-id-type="doi">10.7717/peerj.48/fig-1</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Representative left ventricular pressure traces from perfused hearts.</title>
            <p>Traces are shown for wild-type (WT) and <italic>Slo1</italic><sup>−/−</sup> hearts, in the presence of vehicle (Ctrl.), NS1619 or NS11021, as per the methods. Traces are compressed on the time (<italic>x</italic>) axis. The top and bottom boundaries of the black shaded area represent the systolic and diastolic pressures, respectively. The onset of ischemia (I) and reperfusion (R) are indicated by arrows. Scale bars on each trace represent 10 min. (<italic>x</italic>-axis) and 50 mmHg (<italic>y</italic>-axis).</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/48/fig-1.png"/>
        </fig>
        <fig id="fig-2">
          <object-id pub-id-type="doi">10.7717/peerj.48/fig-2</object-id>
          <label>Figure 2</label>
          <caption>
            <title>SLO1 dependent protection of perfused mouse heart against ischemia-reperfusion (IR) injury.</title>
            <p>Perfused FVB littermate WT (white symbols) and <italic>Slo1</italic><sup>−/−</sup> (gray symbols) mouse hearts were subjected to IR injury. Where indicated, hearts were treated with NS1619 (5 µM) or NS11021 (500 nM) prior to ischemia. (A): Left-ventricular function was determined as rate pressure product (RPP; heart rate × left ventricular developed pressure) and expressed as percent of initial value. Statistical significance between groups was determined using a mixed-effects model. *<italic>p</italic> &lt; 0.05 between NS11021 and control (IR alone), #<italic>p</italic> &lt; 0.05 between NS1619 and control (IR alone). (B): Following IR protocols, hearts were sliced, stained with TTC and fixed to delineate live (red) from dead or infarcted tissue (white). Infarcts were quantified by planimetry and expressed as a percent of the area at risk (100% in this global ischemia model). Images above the graph show representative slices from each group. Within each group, individual values are on the left, and means ± SEM on the right (<italic>N</italic> = 7 for IR group and 6 for all other groups). *<italic>p</italic> &lt; 0.05 between NS11021 and control (IR alone), #<italic>p</italic> &lt; 0.05 between NS1619 and control (IR alone).</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/48/fig-2.png"/>
        </fig>
      </sec>
      <sec>
        <title>Protection of isolated cardiomyocytes by NS1619 and NS11021 is Slo1 independent</title>
        <p><italic>Slo1</italic> mRNA is expressed at low levels in whole heart (<xref ref-type="bibr" rid="ref-18">Chen et al., 2005</xref>; <xref ref-type="bibr" rid="ref-33">Jiang et al., 1999</xref>; <xref ref-type="bibr" rid="ref-57">Tseng-Crank et al., 1994</xref>), and it has been suggested that SLO1 is present in cardiomyocyte mitochondria (<xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>). We therefore hypothesized that SLO1 in cardiomyocyte mitochondria may play a role in mediating the protective effects of NS1619 and NS11021. To test this hypothesis, adult mouse ventricular cardiomyocytes were isolated from WT and <italic>Slo1</italic><sup>−/−</sup> hearts and subjected to simulated IR injury. As expected, both NS1619 and NS11021 elicited cytoprotection (reduced cell death) in response to IR (<xref ref-type="fig" rid="fig-3">Fig. 3</xref>). However, this protection was present in both WT and <italic>Slo1</italic><sup>−/−</sup> derived myocytes, indicating it did not require SLO1 activity. As a control, the mitochondrial K<sub>ATP</sub> opener diazoxide was protective in both WT and <italic>Slo1</italic><sup>−/−</sup> cells. Overall these data suggest that the protection of cardiomyocytes by NS1619 and NS11021 may be due to off-target (non-SLO1) effects of these molecules, as reported elsewhere (<xref ref-type="bibr" rid="ref-46">Park et al., 2007</xref>; <xref ref-type="bibr" rid="ref-50">Saleh et al., 2007</xref>; <xref ref-type="bibr" rid="ref-30">Holland et al., 1996</xref>; <xref ref-type="bibr" rid="ref-1">Aldakkak et al., 2010</xref>; <xref ref-type="bibr" rid="ref-2">Aon et al., 2010</xref>; <xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>; <xref ref-type="bibr" rid="ref-20">Debska et al., 2003</xref>; <xref ref-type="bibr" rid="ref-35">Kicinska &amp; Szewczyk, 2004</xref>).</p>
        <fig id="fig-3">
          <object-id pub-id-type="doi">10.7717/peerj.48/fig-3</object-id>
          <label>Figure 3</label>
          <caption>
            <title>SLO1 independent protection of adult mouse cardiomyocytes against simulated ischemia-reperfusion (IR) injury.</title>
            <p>Myocytes were isolated from adult littermate WT (white) and <italic>Slo1</italic><sup>−/−</sup> (gray) mouse hearts, and used immediately in the model of IR injury. Where indicated, cells were treated with NS1619 (5 µM), NS11021 (500 nM) or diazoxide (DZX, 10 µM). Upon completion of the IR protocol, cell viability was measured via Trypan blue exclusion and expressed as a percent of control (viability in control normoxic groups was: WT 70 ± 3%, <italic>Slo1</italic><sup>−/−</sup> 69 ± 4%). Experimental conditions are listed below the <italic>x</italic>-axis. Data are means ± SEM, with <italic>N</italic> for each group listed in parentheses at the base off each bar. Each <italic>N</italic> represents an independent cardiomyocyte preparation. *<italic>p</italic> &lt; 0.05 vs. IR alone (ANOVA).</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/48/fig-3.png"/>
        </fig>
      </sec>
      <sec>
        <title>NS1619 and NS11021 exhibit Slo1 independent effects on isolated mitochondria</title>
        <p>To directly test whether NS1619 and NS11021 were able to activate BK channels in isolated mitochondria, a modified thallium (<named-content content-type="chemical-compound">Tl<sup>+</sup></named-content>) flux assay was utilized (<xref ref-type="bibr" rid="ref-64">Wojtovich et al., 2010</xref>). As expected, both compounds were able to elicit a <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content> flux, in a manner sensitive to the BK channel blocker paxilline (<xref ref-type="fig" rid="fig-4">Fig. 4</xref>). However, this flux was evident in mitochondria derived from both WT and <italic>Slo1</italic><sup>−/−</sup> hearts, indicating it did not originate at the level of SLO1. Furthermore, bona fide mitochondrial <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels exhibit a slowing of <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content> flux kinetics by increasing concentrations of <named-content content-type="chemical-compound">K<sup>+</sup></named-content> and not <named-content content-type="chemical-compound">Na<sup>+</sup></named-content> (since only <named-content content-type="chemical-compound">K<sup>+</sup></named-content> competes for <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content> uptake). However, such competition was not seen for NS induced <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content> flux (data not shown), suggesting it is not ion-specific. Together these data support the notion that NS compounds have non-specific effects on mitochondria. Such effects may account for the non <italic>Slo1</italic>-dependent protection observed in isolated cardiomyocytes (<xref ref-type="fig" rid="fig-3">Fig. 3</xref>).</p>
        <fig id="fig-4">
          <object-id pub-id-type="doi">10.7717/peerj.48/fig-4</object-id>
          <label>Figure 4</label>
          <caption>
            <title>SLO1 independent <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel activity in isolated mouse heart mitochondria.</title>
            <p>Mitochondria were isolated from littermate WT (white) and <italic>Slo1</italic><sup>−/−</sup> (gray) mouse hearts and loaded with <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content>-sensitive fluorophore. Mitochondrial <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel activity in the presence of NS compounds was determined using the <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content>-flux assay. Data are presented as Δ fluorescence upon <named-content content-type="chemical-compound">Tl<sup>+</sup></named-content> addition to media. ATP was present to block the mK<sub>ATP</sub> channel. The baseline Δ fluorescence (Ctrl, set to 100%) was 24.7 ± 2.3 and 24.9 ± 4.4 arbitrary units in WT (white bars) and <italic>Slo1</italic><sup>−/−</sup> (gray bars), respectively. Experimental conditions are listed below the <italic>x</italic>-axis. Data are means ±SEM, with <italic>N</italic> for each group listed in parentheses at the base off each bar. Each <italic>N</italic> represents an independent mitochondrial preparation. Control, ATP and ATP + Pax data are replicated between panels A and B for comparison *<italic>p</italic> &lt; 0.05 vs. ATP, <sup>†</sup><italic>p</italic> &lt; 0.05 vs. ATP + NS compound (ANOVA).</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/48/fig-4.png"/>
        </fig>
      </sec>
      <sec>
        <title>SLO1 dependent protection in intact hearts requires cardiac neuronal function</title>
        <p>So far, our data show that SLO1 is not required for protection by NS1619 and NS11021 in isolated cardiomyocytes (<xref ref-type="fig" rid="fig-3">Fig. 3</xref>), but is required for protection by these compounds in the intact heart (<xref ref-type="fig" rid="fig-1">Figs. 1</xref> and <xref ref-type="fig" rid="fig-2">2</xref>). This suggests that in the intact heart, protection occurs via SLO1 in a mechanism that is non-cardiomyocyte autonomous. Several non-myocyte cardioprotective mechanisms exist, including remote preconditioning which is thought to comprise a neuronal signaling component (<xref ref-type="bibr" rid="ref-28">Hausenloy &amp; Yellon, 2008</xref>). We therefore sought to investigate a role for SLO1 in cardioprotection via non myocyte signaling, with a focus on intrinsic cardiac neurons. Importantly, the <italic>ex-vivo</italic> heart preparation used herein is denervated, such that surviving neurons are not central but rather they are intrinsic to the heart. In addition SLO1 channel activity has been described in cardiac neurons (<xref ref-type="bibr" rid="ref-23">Franciolini et al., 2001</xref>) and Purkinje fibers  (<xref ref-type="bibr" rid="ref-15">Callewaert, Vereecke &amp; Carmeliet, 1986</xref>), where it plays a role in regulating heart rate (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>; <xref ref-type="bibr" rid="ref-32">Imlach et al., 2010</xref>).</p>
        <fig id="fig-5">
          <object-id pub-id-type="doi">10.7717/peerj.48/fig-5</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Blocking cardiac neuronal function blocks SLO1 dependent protection in the intact heart.</title>
            <p>(A, B): Perfused FVB mouse hearts from WT animals were subjected to IR injury. Where indicated, hearts were treated with NS1619 (5 µM), atpenin A5 (AA5, 10 nM), or hexamethonium (Hex, 500 µM) as detailed in the methods. Left-ventricular function was determined as rate pressure product (RPP; heart rate x left ventricular developed pressure) and expressed as a percent of initial value. Data are split across two panels for clarity. Statistical significance between groups was determined using a mixed-effects model. *<italic>p</italic> &lt; 0.05 vs. IR alone, #<italic>p</italic> &lt; 0.05 vs. NS1619 + IR. (C): Following IR protocols, hearts were sliced, stained with TTC and fixed to delineate live (red) from dead or infarcted tissue (white). Infarcts were quantified by planimetry and expressed as a percent of the area at risk (100% in this global ischemia model). Images above the graph show representative slices from each group. Within each group, individual values are on the left, and means ±SEM on the right (<italic>N</italic> = 8 for IR, 7 for AA5 + IR, and 6 for all other groups). *<italic>p</italic> &lt; 0.05 vs. IR alone, #<italic>p</italic> &lt; 0.05 vs. NS1619 + IR.</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/48/fig-5.png"/>
        </fig>
        <p><xref ref-type="fig" rid="fig-5">Figure 5</xref> shows that blockade of neuronal function with the synaptic transmission inhibitor hexamethonium, prevented cardioprotection (reduction in infarct size) by NS1619 in intact hearts. This effect was specific to SLO1 and NS1619, since hexamethonium had no effect on protection afforded by the mitochondrial K<sub>ATP</sub> channel activator atpenin A5 (<xref ref-type="bibr" rid="ref-62">Wojtovich &amp; Brookes, 2009</xref>). These data also indicate that NS1619 protects via a mechanism that is distinct from mitochondrial K<sub>ATP</sub> channel opening.</p>
        <p>To further investigate the role of cardiac neurons in protection afforded by SLO1 activators, we assessed neuronal status by histochemical staining for acetylcholinesterase activity (AChE). No differences in AChE staining were found between control, IR, and IR + NS1619 hearts, suggesting the acute time frame of IR injury in this model was not sufficient to precipitate neuronal loss (<xref ref-type="fig" rid="fig-6">Fig. 6A–C</xref>). We therefore hypothesized that a more direct test of cardiac neuronal function might be necessary to assess neuronal protection in this acute model. Hence, the response of heart rate to nicotine (which induces transient tachycardia via nicotinic Ach receptors (<xref ref-type="bibr" rid="ref-56">Tosaka et al., 2003</xref>; <xref ref-type="bibr" rid="ref-27">Haass &amp; Kubler, 1997</xref>)) was measured after IR injury. As seen in <xref ref-type="fig" rid="fig-6">Fig. 6D</xref>, no response to nicotine was seen in control hearts subjected to IR, indicating loss of neuronal function. However, hearts protected with NS1619 exhibited a robust post-IR nicotine response, and this effect was blocked by pre-treatment with hexamethonium, indicating a preservation of nicotine-sensitive intrinsic cardiac neurons. Notably, hearts protected with the mK<sub>ATP</sub> opener atpenin A5 did not exhibit a preserved nicotine response. This is consistent with the data in <xref ref-type="fig" rid="fig-4">Fig. 4</xref> showing that even though atpenin A5 was protective, this cardioprotection was insensitive to hexamethonium. Overall these data indicate that both mK<sub>ATP</sub> and SLO1 channels can protect the heart (<xref ref-type="fig" rid="fig-1">Figs. 1</xref>, <xref ref-type="fig" rid="fig-2">2</xref> and <xref ref-type="fig" rid="fig-5">5</xref>), but they do so via distinct mechanisms, the latter requiring cardiac neuron function.</p>
        <fig id="fig-6">
          <object-id pub-id-type="doi">10.7717/peerj.48/fig-6</object-id>
          <label>Figure 6</label>
          <caption>
            <title>Histochemical staining and functional activity of cardiac neurons.</title>
            <p>Perfused FVB mouse hearts from WT animals were subjected to IR injury. Where indicated, hearts were treated with NS1619 (5 µM), atpenin A5 (AA5, 10 nM), hexamethonium (Hex, 500 µM), or combinations of NS1619 + Hex or AA5 + Hex, as detailed in the methods. Panels A–C show representative total heart histochemical acetylcholinesterase (AChE) staining following (A) control perfusion, (B) IR injury and (C) IR with NS1619 pre-treatment. Dorsal side of the heart is shown, with magnifications of boxed areas shown in right panels. (D): Functional activity of cardiac neurons was determined following the six IR protocols used in <xref ref-type="fig" rid="fig-3">Fig. 3</xref>, via the injection of nicotine (100 µM) for 5 min. The peak heart rate increase was found at 2 min, followed by desensitization and subsequent decrease in heart rate. Data are means ±SEM. <italic>N</italic> for each group is shown in parentheses to the right of the legend. Each <italic>N</italic> represents an individual perfused heart. *<italic>p</italic> &lt; 0.05 vs. IR (ANOVA).</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/48/fig-6.png"/>
        </fig>
        <fig id="fig-7">
          <object-id pub-id-type="doi">10.7717/peerj.48/fig-7</object-id>
          <label>Figure 7</label>
          <caption>
            <title>Working model of SLO1 (in)dependent mechanisms of action in NS1619/NS11021 cardioprotection.</title>
            <p>(A): In isolated cardiomyocytes the NS compounds induce cardioprotection independent of SLO1. The ‘target’ remains unclear but may include inhibition of respiration or the uncoupling of oxidative phosphorylation (see text for details). This mechanism is compatible with the lack of evidence for SLO1 in cardiomyocytes. (B): In the whole heart, cardioprotection by NS1619/NS11021 is dependent on SLO1 and is likely mediated via a cell non-autonomous mechanism, involving intrinsic cardiac neurons. A barrier is hypothesized to exist, possibly accounting for the inability of NS compounds to recruit the nonspecific target responsible for protection in myocytes. This explains the lack of ability of NS1619/NS11021 to protect the intact <italic>Slo1</italic><sup>−/−</sup> heart. HEX = hexamethonium.</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/48/fig-7.png"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Together, the current data suggest that the SLO1 openers NS1619 and NS11021 act to preserve intrinsic cardiac neuronal function in IR injury, in a <italic>Slo1</italic> dependent manner, and this leads to protection of myocardium. As such, the function of cardiomyocytes in IR injury can be preserved by activation of a non-cardiomyocyte-autonomous signaling mechanism. From a pharmaco-genomic perspective, this is the first study to show that cardioprotection in the intact heart by the putative SLO1 activators NS1619 and NS11021 actually requires the <italic>Slo1</italic> gene product (<xref ref-type="fig" rid="fig-1">Figs. 1</xref> and <xref ref-type="fig" rid="fig-2">2</xref>).</p>
      <p>Although the chemical structures of NS1619 and NS11021 are quite diverse, an inactive analog of NS11021 (NS13558) does not elicit cardioprotection  (<xref ref-type="bibr" rid="ref-12">Bentzen et al., 2010</xref>), suggesting these molecules bind to a specific target in the whole heart, presumably SLO1. While the mitochondrial K<sub>ATP</sub> channel would appear to be an obvious alternative target for the NS compounds, protection by NS1619 is not blocked by the mK<sub>ATP</sub> blocker 5-HD (<xref ref-type="bibr" rid="ref-17">Cao et al., 2005</xref>), suggesting this is not the case. Rather, the mechanism of protection by SLO1 openers is distinct from that afforded by activation of cardiac mK<sub>ATP</sub> channels (e.g., by diazoxide or atpenin A5), and suggests that non-myocyte and possibly non-mitochondrial <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels are also important in determining responses to ischemia.</p>
      <p>The data in <xref ref-type="fig" rid="fig-5">Figs. 5</xref> and <xref ref-type="fig" rid="fig-6">6</xref> suggest that cardioprotection by SLO1 activators proceeds via intrinsic cardiac neurons, with preservation of neuronal function during IR injury leading to improved cardiac functional recovery, decreased infarct size (<xref ref-type="fig" rid="fig-5">Fig. 5</xref>), and the post-IR ability to mount a tachycardic response to nicotine (<xref ref-type="fig" rid="fig-6">Fig. 6D</xref>). This nicotine response requires both intact cardiac neurons and the ability of myocytes to respond to a tachycardic signal. Notably, hearts protected by mK<sub>ATP</sub> agonist atpenin A5 were fully competent at the contractile level post-IR (<xref ref-type="fig" rid="fig-5">Fig. 5</xref>), but failed to respond to nicotine. This suggests a post-IR defect in a non-cardiomyocyte cell-type, presumably neurons since this is the only other cell type known to be involved in the nicotine response. Post-IR in NS1619 treated hearts responded to nicotine in a manner that was blocked by hexamethonium (<xref ref-type="fig" rid="fig-6">Fig. 6D</xref>), and the preservation of contractile function by NS1619 was also blocked by hexamethonium (<xref ref-type="fig" rid="fig-5">Fig. 5</xref>).</p>
      <p>Overall, the most logical explanation for these data is that NS1619 protection proceeds via SLO1 in cardiac neurons. However, we cannot rule out the possibility that NS1619 acts on other neuronal targets. Unfortunately this cannot be tested experimentally using <italic>Slo1</italic><sup>−/−</sup> mice, because post-IR <italic>Slo1</italic><sup>−/−</sup> hearts treated with NS1619 are incompetent at the contractile level (<xref ref-type="fig" rid="fig-1">Figs. 1</xref> and <xref ref-type="fig" rid="fig-2">2</xref>), so they cannot respond to nicotine anyway, regardless of their neuronal status. Clearly, cardiomyocyte- or neuron-specific <italic>Slo1</italic><sup>−/−</sup> animals would be of enormous benefit in further elucidating the protective mechanism of the NS compounds in future.</p>
      <p>While a role for afferent or efferent neurons (or indeed residual synaptic bulbs from central neurons) cannot be completely ruled out (<xref ref-type="bibr" rid="ref-61">Wenk &amp; McCleskey, 2007</xref>), it should be emphasized that the Langendorff perfused heart preparation is denervated upon removal of the heart from the thorax, and thus the neurons of interest to this study are not afferent or efferent to the central system, but are intrinsic to the heart. The presence of ganglionated plexuses within the heart is well documented (<xref ref-type="bibr" rid="ref-66">Yuan et al., 1994</xref>), and a number of important signaling roles have been assigned to such neurons, including cardiac responses to nitric oxide (<xref ref-type="bibr" rid="ref-7">Armour et al., 1995</xref>), endothelin (<xref ref-type="bibr" rid="ref-3">Armour, 1996</xref>), histamine  (<xref ref-type="bibr" rid="ref-4">Armour, 1996</xref>), angiotensin II (<xref ref-type="bibr" rid="ref-31">Horackova &amp; Armour, 1997</xref>), α/β adrenergic agonists  (<xref ref-type="bibr" rid="ref-5">Armour, 1997</xref>), and nicotine (<xref ref-type="bibr" rid="ref-39">Murphy et al., 1994</xref>). Although the intrinsic cardiac neuronal system has been proposed to play a role in cardiac responses to ischemia  (<xref ref-type="bibr" rid="ref-6">Armour, 1999</xref>), the current study is among the first to directly demonstrate this concept.</p>
      <p>The activity of intrinsic cardiac neurons is increased during ischemia  (<xref ref-type="bibr" rid="ref-22">Foreman et al., 2000</xref>). Furthermore, SLO1 in neurons regulates neurotransmitter release  (<xref ref-type="bibr" rid="ref-59">Wang et al., 2001</xref>), and the loss of SLO1 results in an increased duration of release  (<xref ref-type="bibr" rid="ref-59">Wang et al., 2001</xref>). Thus, activating SLO1 with NS1619 or NS11021 may hyperpolarize neurons, limiting neurotransmitter release and minimizing the neuronal depolarization and excitotoxicity associated with ischemic events (<xref ref-type="bibr" rid="ref-26">Gribkoff et al., 2001</xref>). In simple terms, the NS compounds may prevent excitotoxicity. The ability to modulate cardiac neuronal activity in this manner is a promising therapeutic avenue for ischemic injury (<xref ref-type="bibr" rid="ref-6">Armour, 1999</xref>). Recently, several non-myocyte cell types in the heart have emerged as key players in the response to ischemic injury, including cardiac fibroblasts (<xref ref-type="bibr" rid="ref-34">Kawaguchi et al., 2011</xref>), cardiac mast cells (<xref ref-type="bibr" rid="ref-48">Reid et al., 2011</xref>; <xref ref-type="bibr" rid="ref-36">Koda et al., 2010</xref>), and cardiac stem/progenitor cells (<xref ref-type="bibr" rid="ref-52">Shah et al., 2011</xref>). At this stage, it is not clear whether the cardioprotection observed herein represents a direct effect of cardiac neurons on cardiomyocytes, and the potential involvement of additional intermediary cell types in transmitting the protective signal cannot be excluded.</p>
      <p>The precise sub-cellular location of SLO1 required for protection by NS1619 and NS11021 remains unclear. Early work on the role of SLO1 in cardioprotection found no expression on the surface of cardiomyocytes (<xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>). When single-channel recordings of a <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-dependent <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel were made in human glioma cell mitochondria (<xref ref-type="bibr" rid="ref-53">Siemen et al., 1999</xref>) a consensus emerged that the cardioprotective effect of SLO1 activators was likely due to a SLO1 channel in cardiomyocyte mitochondria (<xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>). Observations that the SLO channel blocker paxilline abrogates protection by NS1619 and NS11021 (<xref ref-type="bibr" rid="ref-14">Bentzen et al., 2009</xref>; <xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>), as well as the protection afforded by APC (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>), are often invoked as proof for the existence of a “cardiac mitochondrial <named-content content-type="chemical-compound">K<sub>Ca</sub></named-content> channel”, and this naming convention is consistent with the fact that mammalian SLO1 is a <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content> sensitive isoform of SLO (<xref ref-type="bibr" rid="ref-51">Salkoff et al., 2006</xref>). Further support comes from immunological studies, in which antibodies directed against the canonical SLO1 (110–130 kDa) detect the protein in mitochondrial fractions (120, 80, and 55 kDa) (<xref ref-type="bibr" rid="ref-65">Xu et al., 2002</xref>; <xref ref-type="bibr" rid="ref-24">Fretwell &amp; Dickenson, 2009</xref>; <xref ref-type="bibr" rid="ref-60">Wang et al., 2004</xref>; <xref ref-type="bibr" rid="ref-54">Singh, Stefani &amp; Toro, 2012</xref>).</p>
      <p>More recently however, the consensus view that SLO1 is a mitochondrial <named-content content-type="chemical-compound">K<sub>Ca</sub></named-content> channel important for cardioprotection has been challenged by our observation that SLO1 is dispensable for APC and IPC (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>). Furthermore, although the SLO auxiliary subunit β4 (<xref ref-type="bibr" rid="ref-24">Fretwell &amp; Dickenson, 2009</xref>; <xref ref-type="bibr" rid="ref-47">Piwonska et al., 2008</xref>; <xref ref-type="bibr" rid="ref-55">Skalska et al., 2009</xref>; <xref ref-type="bibr" rid="ref-43">Ohya et al., 2005</xref>) has been found in mitochondria, this subunit renders SLO1 resistant to charybdotoxin and iberiotoxin – toxins that block the effects of NS1619 on mitochondria  (<xref ref-type="bibr" rid="ref-37">Meera, Wallner &amp; Toro, 2000</xref>). We have also shown that in the model organism <italic>C. elegans</italic>, the SLO2 isoform of the channel underlies both APC and mitochondrial <named-content content-type="chemical-compound">K<sup>+</sup></named-content> flux (<xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>). While studies are ongoing to confirm the identity of the mitochondrial BK channel, it seems clear that the simple picture of a SLO1 channel in cardiomyocyte mitochondria as the underlying mechanism of cardioprotection by APC or NS compounds is untenable. Indeed, the data in <xref ref-type="fig" rid="fig-3">Fig. 3</xref> show that NS compounds elicited <named-content content-type="chemical-compound">K<sup>+</sup></named-content> transport in isolated mitochondria independent of SLO1, adding to the body of evidence for off-target effects of these compounds at the mitochondrial level.</p>
      <p>Subsequently, the question arises as to the mechanism by which the SLO1 openers NS1619 and NS11021 can elicit protection in isolated cardiomyocytes (<xref ref-type="bibr" rid="ref-24">Fretwell &amp; Dickenson, 2009</xref>; <xref ref-type="bibr" rid="ref-19">Chmielewska &amp; Malinska, 2011</xref>), in a <italic>Slo1</italic> independent manner (<xref ref-type="fig" rid="fig-3">Fig. 3</xref>). It seems reasonable to suggest that the well-documented off-target effects of these molecules (reinforced by data in <xref ref-type="fig" rid="fig-4">Fig. 4</xref>) may underlie such protection (<xref ref-type="bibr" rid="ref-1">Aldakkak et al., 2010</xref>; <xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>; <xref ref-type="bibr" rid="ref-20">Debska et al., 2003</xref>; <xref ref-type="bibr" rid="ref-35">Kicinska &amp; Szewczyk, 2004</xref>). Both NS1619 and NS11021 have been reported to inhibit respiration (<xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>; <xref ref-type="bibr" rid="ref-35">Kicinska &amp; Szewczyk, 2004</xref>), promote mitochondrial depolarization (<xref ref-type="bibr" rid="ref-2">Aon et al., 2010</xref>; <xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>; <xref ref-type="bibr" rid="ref-20">Debska et al., 2003</xref>; <xref ref-type="bibr" rid="ref-35">Kicinska &amp; Szewczyk, 2004</xref>) and cause mitochondrial swelling independent of <named-content content-type="chemical-compound">K<sup>+</sup></named-content> (<xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>; <xref ref-type="bibr" rid="ref-11">Bednarczyk, Barker &amp; Halestrap, 2008</xref>) suggesting they can impact non-specific ion transport mechanisms (<xref ref-type="bibr" rid="ref-1">Aldakkak et al., 2010</xref>; <xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>). NS1619 has also been shown to increase mitochondrial ROS generation without depolarization (<xref ref-type="bibr" rid="ref-29">Heinen et al., 2007</xref>), and a role for small amounts of ROS in cardioprotective signaling is well known (<xref ref-type="bibr" rid="ref-58">Vanden Hoek et al., 1998</xref>). Alternatively, NS1619 and NS11021 may protect cardiomyocytes via non-mitochondrial targets that remain to be identified.</p>
      <p>Mitochondrial ion channels such as the mK<sub>ATP</sub> and SLO2 remain important mediators of IPC and APC cardioprotective signaling (<xref ref-type="bibr" rid="ref-21">Facundo, Fornazari &amp; Kowaltowski, 2006</xref>; <xref ref-type="bibr" rid="ref-63">Wojtovich et al., 2011</xref>; <xref ref-type="bibr" rid="ref-40">Murphy &amp; Steenbergen, 2007</xref>; <xref ref-type="bibr" rid="ref-25">Garlid et al., 2009</xref>; <xref ref-type="bibr" rid="ref-45">O’Rourke, 2004</xref>), and it should be emphasized that the data presented herein do not preclude the presence of a SLO1 channel in the mitochondria. <italic>Slo1</italic> has many splice variants  (<xref ref-type="bibr" rid="ref-51">Salkoff et al., 2006</xref>) and it is possible that such variants may be present in the mitochondrion, but these channels are either not the primary target or lack the binding site necessary to respond to NS1619 and NS11021. Furthermore, the <italic>Slo1</italic><sup>−/−</sup> mouse used in these studies has a deletion of Exon 1, which encodes the S0 domain required for channel function (<xref ref-type="bibr" rid="ref-38">Meredith et al., 2004</xref>; <xref ref-type="bibr" rid="ref-68">Zarei et al., 2001</xref>; <xref ref-type="bibr" rid="ref-67">Zarei et al., 2004</xref>), making it unlikely that a functional splice variant is present in the knockout. Further studies are needed to determine the nature of any SLO1 in mitochondria, or to investigate the intriguing notion that SLO1 may reside in the mitochondria of intrinsic cardiac neurons.</p>
      <p>A surprising paradox emerges when comparing the whole heart and cardiomyocyte effects of NS1619 and NS11021 (<xref ref-type="fig" rid="fig-2">Figs. 2</xref> and <xref ref-type="fig" rid="fig-3">3</xref>). Specifically, if these compounds are capable of protecting isolated cardiomyocytes in a <italic>Slo1</italic> independent manner, why is this mechanism of protection not accessible in whole hearts? If it were, the compounds should protect the <italic>Slo1</italic><sup>−/−</sup> heart. One possibility may be the different experimental systems, or that the isolated myocytes does not express SLO1, which may promote nonspecific actions of these compounds. Another possibility is that a barrier exists in the intact heart (possibly a vascular diffusional barrier) which prevents NS1619 and NS11021 from activating the protective pathway observed in cells. Notably, attempts to overcome this limitation by using high concentrations of NS1619 (30 µM) in the intact heart led to an exacerbation of IR injury (data not shown), which may be related to reports that high concentrations of this compound can depolarize mitochondria (<xref ref-type="bibr" rid="ref-16">Cancherini, Queliconi &amp; Kowaltowski, 2007</xref>). Notably, a recent review article stated that “<italic>In whole heart experiments the effective concentration of NS1619 is actually lower due to limited diffusion of the drug to its site of action, and thus, it promotes cardioprotection instead of mitochondrial damage and heart stress.”</italic> (<xref ref-type="bibr" rid="ref-54">Singh, Stefani &amp; Toro, 2012</xref>)</p>
      <p>Clearly in the intact heart, something prevents NS1619 and NS11021 from protecting myocytes directly, such that the only avenue of protection available to these molecules is via SLO1, and knocking out the channel abrogates this protective mechanism. A schematic outlining the different actions of NS1619 and NS11021 in isolated myocytes vs. intact hearts is shown in <xref ref-type="fig" rid="fig-7">Fig. 7</xref>, with the exact nature of the protective signal initiated at the cardiac neuronal level by SLO1 openers still to be elucidated.</p>
      <p>In conclusion, the SLO1 channel is a cardioprotective target of NS1619 and NS11021, and these molecules are important tools for assessing SLO1 function in the whole heart. The molecules elicit protection in isolated cardiomyocytes that is independent of SLO1, possibly mediated by off-target effects. In contrast at the whole heart level, protection by NS1619 and NS11021 absolutely requires SLO1, and preserves intrinsic cardiac neuronal function. Collectively these studies support the notion that intrinsic cardiac neurons are important mediators of cardioprotection, and may be a therapeutic target (<xref ref-type="bibr" rid="ref-28">Hausenloy &amp; Yellon, 2008</xref>). <def-list id="dl1"><title>Abbreviations</title><def-item><term>NS1619</term><def><p>1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one</p></def></def-item><def-item><term>NS11021</term><def><p>1-(3,5-bis-trifluoromethyl-phenyl)-3-[4-bromo-2-(1H-tetrazol-5-yl)-phenyl]-thiourea</p></def></def-item><def-item><term>BTC-AM</term><def><p>Benzothiazole coumarin acetyoxymethyl ester</p></def></def-item><def-item><term>BK</term><def><p>large-conductance “big” <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel</p></def></def-item><def-item><term>mK<sub>ATP</sub></term><def><p>mitochondrial ATP-sensitive <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel</p></def></def-item><def-item><term>TTC</term><def><p>Tetrazolium chloride</p></def></def-item><def-item><term>WT</term><def><p>Wild-type</p></def></def-item></def-list>
         </p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank James Melvin (NIH) and Richard Aldrich (University of Texas at Austin) for the <italic>Slo1</italic><sup>−/−</sup> mice.</p>
    </ack>
    <sec sec-type="additional-information">
      <title>Additional Information and Declarations</title>
      <fn-group content-type="competing-interests">
        <title>Competing Interests</title>
        <fn id="conflict-1" fn-type="con">
          <p>Morten Grunnet is a former employee of Neurosearch A/S. Morten Grunnet is a current employee of Lundbeck A/S. Paul Brookes is an Academic Editor for PeerJ.</p>
        </fn>
      </fn-group>
      <fn-group content-type="author-contributions">
        <title>Author Contributions</title>
        <fn id="contribution-1" fn-type="con">
          <p><xref ref-type="contrib" rid="author-1">Andrew P. Wojtovich</xref> conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper.</p>
        </fn>
        <fn id="contribution-2" fn-type="con">
          <p><xref ref-type="contrib" rid="author-2">Sergiy M. Nadtochiy</xref> performed the experiments, analyzed the data.</p>
        </fn>
        <fn id="contribution-3" fn-type="con">
          <p><xref ref-type="contrib" rid="author-3">William R. Urciuoli</xref> performed the experiments.</p>
        </fn>
        <fn id="contribution-4" fn-type="con">
          <p><xref ref-type="contrib" rid="author-4">Charles O. Smith</xref> analyzed the data.</p>
        </fn>
        <fn id="contribution-5" fn-type="con">
          <p><xref ref-type="contrib" rid="author-5">Morten Grunnet</xref> analyzed the data, contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-6" fn-type="con">
          <p><xref ref-type="contrib" rid="author-6">Keith Nehrke</xref> conceived and designed the experiments, analyzed the data, contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-7" fn-type="con">
          <p><xref ref-type="contrib" rid="author-7">Paul S. Brookes</xref> conceived and designed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper.</p>
        </fn>
      </fn-group>
      <fn-group content-type="other">
        <title>Animal Ethics</title>
        <fn id="addinfo-1" fn-type="other">
          <p>The following information was supplied relating to ethical approvals (i.e. approving body and any reference numbers):</p>
          <p>University of Rochester UCAR (University Committee on Animal Resources).</p>
          <p>All studies performed under protocol # UCAR 2010-030</p>
        </fn>
      </fn-group>
    </sec>
    <ref-list content-type="authoryear">
      <title>References</title>
      <ref id="ref-1">
        <label>Aldakkak et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aldakkak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stowe</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Kwok</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Camara</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial matrix <named-content content-type="chemical-compound">K<sup>+</sup></named-content> flux independent of large-conductance <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel opening</article-title>
          <source>American Journal of Physiology – Cell Physiology</source>
          <year iso-8601-date="2010">2010</year>
          <volume>298</volume>
          <fpage>C530</fpage>
          <lpage>C541</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpcell.00468.2009</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-2">
        <label>Aon et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aon</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Cortassa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Grunnet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O’Rourke</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Energetic performance is improved by specific activation of <named-content content-type="chemical-compound">K<sup>+</sup></named-content> fluxes through K<sub>Ca</sub> channels in heart mitochondria</article-title>
          <source>Biochimica et Biophysica Acta</source>
          <year iso-8601-date="2010">2010</year>
          <volume>1797</volume>
          <fpage>71</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbabio.2009.08.002</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-3">
        <label>Armour (1996)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Comparative effects of endothelin and neurotensin on intrinsic cardiac neurons in situ</article-title>
          <source>Peptides</source>
          <year iso-8601-date="1996">1996</year>
          <volume>17</volume>
          <fpage>1047</fpage>
          <lpage>1052</lpage>
          <pub-id pub-id-type="doi">10.1016/0196-9781(96)00134-9</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-4">
        <label>Armour (1996)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Histamine-sensitive intrinsic cardiac and intrathoracic extracardiac neurons influence cardiodynamics</article-title>
          <source>American Journal of Physiology</source>
          <year iso-8601-date="1996">1996</year>
          <volume>270</volume>
          <fpage>R906</fpage>
          <lpage>R913</lpage>
        </element-citation>
      </ref>
      <ref id="ref-5">
        <label>Armour (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors</article-title>
          <source>Canadian Journal of Cardiology</source>
          <year iso-8601-date="1997">1997</year>
          <volume>13</volume>
          <fpage>277</fpage>
          <lpage>284</lpage>
        </element-citation>
      </ref>
      <ref id="ref-6">
        <label>Armour (1999)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Myocardial ischaemia and the cardiac nervous system</article-title>
          <source>Cardiovascular Research</source>
          <year iso-8601-date="1999">1999</year>
          <volume>41</volume>
          <fpage>41</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(98)00252-1</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-7">
        <label>Armour et al. (1995)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Losier</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ellenberger</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Modulation of intrinsic cardiac neuronal activity by nitric oxide donors induces cardiodynamic changes</article-title>
          <source>American Journal of Physiology</source>
          <year iso-8601-date="1995">1995</year>
          <volume>268</volume>
          <fpage>R403</fpage>
          <lpage>R413</lpage>
        </element-citation>
      </ref>
      <ref id="ref-8">
        <label>Baayen (2008)</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Baayen</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <source>Analyzing Linguistic Data: A Practical Introduction to Statistics Using R</source>
          <year iso-8601-date="2008">2008</year>
          <publisher-loc>Cambridge</publisher-loc>
          <publisher-name>Cambridge University Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="ref-9">
        <label>Baayen (2009)</label>
        <element-citation publication-type="other">
          <person-group>
            <name>
              <surname>Baayen</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <comment>2009. languageR: Data sets and functions with “Analyzing Linguistic Data: A practical introduction to statistics”. R package version 0.955</comment>
        </element-citation>
      </ref>
      <ref id="ref-10">
        <label>Bates &amp; Maechler (2009)</label>
        <element-citation publication-type="other">
          <person-group>
            <name>
              <surname>Bates</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Maechler</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <comment>lme4: Linear mixed-effects models using S4 classes. R package version 0.999375-32. 2009</comment>
        </element-citation>
      </ref>
      <ref id="ref-11">
        <label>Bednarczyk, Barker &amp; Halestrap (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bednarczyk</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Halestrap</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Determination of the rate of <named-content content-type="chemical-compound">K<sup>+</sup></named-content> movement through potassium channels in isolated rat heart and liver mitochondria</article-title>
          <source>Biochimica et Biophysica Acta</source>
          <year iso-8601-date="2008">2008</year>
          <volume>1777</volume>
          <fpage>540</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbabio.2008.04.018</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-12">
        <label>Bentzen et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentzen</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Olesen</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Grunnet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nardi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and characterisation of NS13558: a new important tool for addressing K<sub>Ca</sub>1.1 channel function ex vivo</article-title>
          <source>Naunyn-Schmiedeberg’s Archives of Pharmacology</source>
          <year iso-8601-date="2010">2010</year>
          <volume>381</volume>
          <fpage>271</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1007/s00210-009-0456-2</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-13">
        <label>Bentzen et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentzen</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Nardi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Calloe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Madsen</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Olesen</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Grunnet</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The small molecule NS11021 is a potent and specific activator of <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated big-conductance <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels</article-title>
          <source>Molecular Pharmacology</source>
          <year iso-8601-date="2007">2007</year>
          <volume>72</volume>
          <fpage>1033</fpage>
          <lpage>1044</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.107.038331</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-14">
        <label>Bentzen et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentzen</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Osadchii</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jespersen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Olesen</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Grunnet</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Activation of big conductance <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels (BK) protects the heart against ischemia-reperfusion injury</article-title>
          <source>Pflugers Archiv. European Journal of Physiology</source>
          <year iso-8601-date="2009">2009</year>
          <volume>457</volume>
          <fpage>979</fpage>
          <lpage>988</lpage>
          <pub-id pub-id-type="doi">10.1007/s00424-008-0583-5</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-15">
        <label>Callewaert, Vereecke &amp; Carmeliet (1986)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Callewaert</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vereecke</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carmeliet</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Existence of a calcium-dependent potassium channel in the membrane of cow cardiac Purkinje cells</article-title>
          <source>Pflugers Archiv. European Journal of Physiology</source>
          <year iso-8601-date="1986">1986</year>
          <volume>406</volume>
          <fpage>424</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00590947</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-16">
        <label>Cancherini, Queliconi &amp; Kowaltowski (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cancherini</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Queliconi</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Kowaltowski</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological and physiological stimuli do not promote <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-sensitive <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel activity in isolated heart mitochondria</article-title>
          <source>Cardiovascular Research</source>
          <year iso-8601-date="2007">2007</year>
          <volume>73</volume>
          <fpage>720</fpage>
          <lpage>728</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cardiores.2006.11.035</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-17">
        <label>Cao et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning</article-title>
          <source>Journal of Pharmacology and Experimental Therapeutics</source>
          <year iso-8601-date="2005">2005</year>
          <volume>312</volume>
          <fpage>644</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.104.074476</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-18">
        <label>Chen et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>McClafferty</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hammond</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Huibant</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ruth</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Shipston</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Functionally diverse complement of large conductance calcium- and voltage-activated potassium channel (BK) alpha-subunits generated from a single site of splicing</article-title>
          <source>Journal of Biological Chemistry</source>
          <year iso-8601-date="2005">2005</year>
          <volume>280</volume>
          <fpage>33599</fpage>
          <lpage>33609</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M505383200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-19">
        <label>Chmielewska &amp; Malinska (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chmielewska</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Malinska</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Cytoprotective action of the potassium channel opener NS1619 under conditions of disrupted calcium homeostasis</article-title>
          <source>Pharmacological Reports</source>
          <year iso-8601-date="2011">2011</year>
          <volume>63</volume>
          <fpage>176</fpage>
          <lpage>183</lpage>
        </element-citation>
      </ref>
      <ref id="ref-20">
        <label>Debska et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Debska</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kicinska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dobrucki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dworakowska</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nurowska</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Skalska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dolowy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Szewczyk</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Large-conductance <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells</article-title>
          <source>Biochemical Pharmacology</source>
          <year iso-8601-date="2003">2003</year>
          <volume>65</volume>
          <fpage>1827</fpage>
          <lpage>1834</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-2952(03)00180-1</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-21">
        <label>Facundo, Fornazari &amp; Kowaltowski (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Facundo</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Fornazari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kowaltowski</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Tissue protection mediated by mitochondrial <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels</article-title>
          <source>Biochimica et Biophysica Acta</source>
          <year iso-8601-date="2006">2006</year>
          <volume>1762</volume>
          <fpage>202</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbadis.2005.06.003</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-22">
        <label>Foreman et al. (2000)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foreman</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Linderoth</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ardell</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Barron</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Chandler</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hull</surname>
              <given-names>SS</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>TerHorst</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>DeJongste</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris</article-title>
          <source>Cardiovascular Research</source>
          <year iso-8601-date="2000">2000</year>
          <volume>47</volume>
          <fpage>367</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(00)00095-X</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-23">
        <label>Franciolini et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franciolini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hogg</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Catacuzzeno</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Petris</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Trequattrini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Large-conductance calcium-activated potassium channels in neonatal rat intracardiac ganglion neurons</article-title>
          <source>Pflugers Archiv. European Journal of Physiology</source>
          <year iso-8601-date="2001">2001</year>
          <volume>441</volume>
          <fpage>629</fpage>
          <lpage>638</lpage>
          <pub-id pub-id-type="doi">10.1007/s004240000471</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-24">
        <label>Fretwell &amp; Dickenson (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fretwell</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dickenson</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Role of large-conductance <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated potassium channels in adenosine A(1) receptor-mediated pharmacological preconditioning in H9c2 cells</article-title>
          <source>European Journal of Pharmacology</source>
          <year iso-8601-date="2009">2009</year>
          <volume>618</volume>
          <fpage>37</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejphar.2009.07.008</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-25">
        <label>Garlid et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garlid</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Quinlan</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Pierre</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Dos</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotective signaling to mitochondria</article-title>
          <source>Journal of Molecular and Cellular Cardiology</source>
          <year iso-8601-date="2009">2009</year>
          <volume>46</volume>
          <fpage>858</fpage>
          <lpage>866</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.11.019</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-26">
        <label>Gribkoff et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gribkoff</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Starrett</surname>
              <given-names>JE</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Dworetzky</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Hewawasam</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Boissard</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Frantz</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Heman</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hibbard</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Huston</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Krishnan</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Kinney</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Lombardo</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Meanwell</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Molinoff</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Ortiz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pajor</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pieschl</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Post-Munson</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Signor</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Srinivas</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Taber</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Thalody</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Trojnacki</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Wiener</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yeleswaram</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yeola</surname>
              <given-names>ZW</given-names>
            </name>
          </person-group>
          <article-title>Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels</article-title>
          <source>Nature Medicine</source>
          <year iso-8601-date="2001">2001</year>
          <volume>7</volume>
          <fpage>471</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="doi">10.1038/86546</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-27">
        <label>Haass &amp; Kubler (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haass</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kubler</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Nicotine and sympathetic neurotransmission</article-title>
          <source>Cardiovascular Drugs and Therapy</source>
          <year iso-8601-date="1997">1997</year>
          <volume>10</volume>
          <fpage>657</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00053022</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-28">
        <label>Hausenloy &amp; Yellon (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hausenloy</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Remote ischaemic preconditioning: underlying mechanisms and clinical application</article-title>
          <source>Cardiovascular Research</source>
          <year iso-8601-date="2008">2008</year>
          <volume>79</volume>
          <fpage>377</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="doi">10.1093/cvr/cvn114</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-29">
        <label>Heinen et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Camara</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Aldakkak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Riess</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Stowe</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-induced <named-content content-type="chemical-compound">K<sup>+</sup></named-content> influx increases respiration and enhances ROS production while maintaining membrane potential</article-title>
          <source>American Journal of Physiology – Cell Physiology</source>
          <year iso-8601-date="2007">2007</year>
          <volume>292</volume>
          <fpage>C148</fpage>
          <lpage>C156</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpcell.00215.2006</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-30">
        <label>Holland et al. (1996)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holland</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Langton</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Standen</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Effects of the <named-content content-type="chemical-compound">BK<sub>Ca</sub></named-content> channel activator, NS1619, on rat cerebral artery smooth muscle</article-title>
          <source>British Journal of Pharmacology</source>
          <year iso-8601-date="1996">1996</year>
          <volume>117</volume>
          <fpage>119</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1476-5381.1996.tb15163.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-31">
        <label>Horackova &amp; Armour (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horackova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>ANG II modifies cardiomyocyte function via extracardiac and intracardiac neurons: in situ and in vitro studies</article-title>
          <source>American Journal of Physiology</source>
          <year iso-8601-date="1997">1997</year>
          <volume>272</volume>
          <fpage>R766</fpage>
          <lpage>R775</lpage>
        </element-citation>
      </ref>
      <ref id="ref-32">
        <label>Imlach et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imlach</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Finch</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Meredith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Dalziel</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>A role for BK channels in heart rate regulation in rodents</article-title>
          <source>PLoS ONE</source>
          <year iso-8601-date="2010">2010</year>
          <volume>5</volume>
          <elocation-id>e8698</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0008698</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-33">
        <label>Jiang et al. (1999)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wallner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meera</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Toro</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Human and rodent MaxiK channel beta-subunit genes: cloning and characterization</article-title>
          <source>Genomics</source>
          <year iso-8601-date="1999">1999</year>
          <volume>55</volume>
          <fpage>57</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1998.5627</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-34">
        <label>Kawaguchi et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kashima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Usui</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Morimoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Izawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Masumoto</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koyama</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hongo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Noda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sagara</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury</article-title>
          <source>Circulation</source>
          <year iso-8601-date="2011">2011</year>
          <volume>123</volume>
          <fpage>594</fpage>
          <lpage>604</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.982777</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-35">
        <label>Kicinska &amp; Szewczyk (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kicinska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Szewczyk</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Large-conductance potassium cation channel opener NS1619 inhibits cardiac mitochondria respiratory chain</article-title>
          <source>Toxicology Mechanisms and Methods</source>
          <year iso-8601-date="2004">2004</year>
          <volume>14</volume>
          <fpage>59</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1080/15376520490257482</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-36">
        <label>Koda et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Salazar-Rodriguez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Corti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>NY</given-names>
            </name>
            <name>
              <surname>Estephan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Mochly-Rosen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Levi</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells</article-title>
          <source>Circulation</source>
          <year iso-8601-date="2010">2010</year>
          <volume>122</volume>
          <fpage>771</fpage>
          <lpage>781</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.952481</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-37">
        <label>Meera, Wallner &amp; Toro (2000)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meera</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wallner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Toro</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel resistant to charybdotoxin and iberiotoxin</article-title>
          <source>Proceedings of the National Academy of Sciences of the United States of America</source>
          <year iso-8601-date="2000">2000</year>
          <volume>97</volume>
          <fpage>5562</fpage>
          <lpage>5567</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.100118597</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-38">
        <label>Meredith et al. (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meredith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Thorneloe</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Aldrich</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Overactive bladder and incontinence in the absence of the BK large conductance <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel</article-title>
          <source>Journal of Biological Chemistry</source>
          <year iso-8601-date="2004">2004</year>
          <volume>279</volume>
          <fpage>36746</fpage>
          <lpage>36752</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M405621200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-39">
        <label>Murphy et al. (1994)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>O’Blenes</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Functional capacity of nicotine-sensitive canine intrinsic cardiac neurons to modify the heart</article-title>
          <source>American Journal of Physiology</source>
          <year iso-8601-date="1994">1994</year>
          <volume>266</volume>
          <fpage>R1127</fpage>
          <lpage>R1135</lpage>
        </element-citation>
      </ref>
      <ref id="ref-40">
        <label>Murphy &amp; Steenbergen (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Steenbergen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Preconditioning: the mitochondrial connection</article-title>
          <source>Annual Review of Physiology</source>
          <year iso-8601-date="2007">2007</year>
          <volume>69</volume>
          <fpage>51</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.physiol.69.031905.163645</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-41">
        <label>Nadtochiy et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nadtochiy</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Burwell</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Ingraham</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Spencer</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Pinkert</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Brookes</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine</article-title>
          <source>Journal of Molecular and Cellular Cardiology</source>
          <year iso-8601-date="2009">2009</year>
          <volume>46</volume>
          <fpage>960</fpage>
          <lpage>968</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.01.012</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-42">
        <label>Nadtochiy et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nadtochiy</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Redman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Brookes</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>Lysine deacetylation in ischaemic preconditioning: the role of SIRT1</article-title>
          <source>Cardiovascular Research</source>
          <year iso-8601-date="2011">2011</year>
          <volume>89</volume>
          <fpage>643</fpage>
          <lpage>649</lpage>
          <pub-id pub-id-type="doi">10.1093/cvr/cvq287</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-43">
        <label>Ohya et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kuwata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Muraki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Imaizumi</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotective effects of estradiol include the activation of large-conductance <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels in cardiac mitochondria</article-title>
          <source>Heart and Circulatory Physiology: American Journal of Physiology</source>
          <year iso-8601-date="2005">2005</year>
          <volume>289</volume>
          <fpage>H1635</fpage>
          <lpage>H1642</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00016.2005</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-44">
        <label>O’Rourke (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O’Rourke</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial ion channels</article-title>
          <source>Annual Review of Psychology</source>
          <year iso-8601-date="2007">2007</year>
          <volume>69</volume>
          <fpage>19</fpage>
          <lpage>49</lpage>
        </element-citation>
      </ref>
      <ref id="ref-45">
        <label>O’Rourke (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O’Rourke</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Evidence for mitochondrial <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels and their role in cardioprotection</article-title>
          <source>Circulation Research</source>
          <year iso-8601-date="2004">2004</year>
          <volume>94</volume>
          <fpage>420</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.0000117583.66950.43</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-46">
        <label>Park et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Son</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The mitochondrial <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content>channel activator, NS 1619 inhibits L-type <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content> channels in rat ventricular myocytes</article-title>
          <source>Biochemical and Biophysical Research Communications</source>
          <year iso-8601-date="2007">2007</year>
          <volume>362</volume>
          <fpage>31</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.07.057</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-47">
        <label>Piwonska et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piwonska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wilczek</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Szewczyk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wilczynski</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Differential distribution of <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated potassium channel beta4 subunit in rat brain: immunolocalization in neuronal mitochondria</article-title>
          <source>Neuroscience</source>
          <year iso-8601-date="2008">2008</year>
          <volume>153</volume>
          <fpage>446</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.01.050</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-48">
        <label>Reid et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reid</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Brazin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Morrey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Levi</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system</article-title>
          <source>Current Pharmaceutical Design</source>
          <year iso-8601-date="2011">2011</year>
          <volume>17</volume>
          <fpage>3744</fpage>
          <lpage>3752</lpage>
          <pub-id pub-id-type="doi">10.2174/138161211798357908</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-49">
        <label>Rysevaite et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rysevaite</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saburkina</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pauziene</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Noujaim</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Jalife</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pauza</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart</article-title>
          <source>Heart Rhythm</source>
          <year iso-8601-date="2011">2011</year>
          <volume>8</volume>
          <fpage>448</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="doi">10.1016/j.hrthm.2010.11.019</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-50">
        <label>Saleh et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saleh</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Angermann</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Sones</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Leblanc</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>IA</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-gated Cl- currents by the calcium-dependent <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel modulators NS1619 [1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2 H-benzimidazol-2-one] and isopimaric acid</article-title>
          <source>Journal of Pharmacology and Experimental Therapeutics</source>
          <year iso-8601-date="2007">2007</year>
          <volume>321</volume>
          <fpage>1075</fpage>
          <lpage>1084</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.106.118786</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-51">
        <label>Salkoff et al. (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salkoff</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Santi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>High-conductance potassium channels of the SLO family</article-title>
          <source>Nature Reviews. Neuroscience</source>
          <year iso-8601-date="2006">2006</year>
          <volume>7</volume>
          <fpage>921</fpage>
          <lpage>931</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn1992</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-52">
        <label>Shah et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shah</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Youngquist</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>McClung</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Tzvetkova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hanif</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Rosborough</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Niemann</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model</article-title>
          <source>Journal of Interferon and Cytokine Research</source>
          <year iso-8601-date="2011">2011</year>
          <volume>31</volume>
          <fpage>509</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="doi">10.1089/jir.2010.0133</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-53">
        <label>Siemen et al. (1999)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siemen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Loupatatzis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Borecky</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gulbins</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title><named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line</article-title>
          <source>Biochemical and Biophysical Research Communications</source>
          <year iso-8601-date="1999">1999</year>
          <volume>257</volume>
          <fpage>549</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="doi">10.1006/bbrc.1999.0496</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-54">
        <label>Singh, Stefani &amp; Toro (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stefani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Toro</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Intracellular BK<sub>Ca</sub>(iBK<sub>Ca</sub>) channels</article-title>
          <source>Journal of Physiology</source>
          <year iso-8601-date="2012">2012</year>
          <volume>590</volume>
          <fpage>5937</fpage>
          <lpage>5947</lpage>
          <pub-id pub-id-type="doi">10.1113/jphysiol.2011.215533</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-55">
        <label>Skalska et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skalska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bednarczyk</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Piwonska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kulawiak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wilczynski</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dolowy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kudin</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Kunz</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Szewczyk</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Calcium ions regulate <named-content content-type="chemical-compound">K<sup>+</sup></named-content> uptake into brain mitochondria: the evidence for a novel potassium channel</article-title>
          <source>International Journal of Molecular Sciences</source>
          <year iso-8601-date="2009">2009</year>
          <volume>10</volume>
          <fpage>1104</fpage>
          <lpage>1120</lpage>
          <pub-id pub-id-type="doi">10.3390/ijms10031104</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-56">
        <label>Tosaka et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tosaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Casimiro</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Rong</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Tella</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Katchman</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Pezzullo</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Pfeifer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ebert</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Nicotine induces a long QT phenotype in Kcnq1-deficient mouse hearts</article-title>
          <source>Journal of Pharmacology and Experimental Therapeutics</source>
          <year iso-8601-date="2003">2003</year>
          <volume>306</volume>
          <fpage>980</fpage>
          <lpage>987</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.103.053017</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-57">
        <label>Tseng-Crank et al. (1994)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tseng-Crank</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Mertz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Godinot</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>DiChiara</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Reinhart</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Cloning, expression, and distribution of functionally distinct <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel isoforms from human brain</article-title>
          <source>Neuron</source>
          <year iso-8601-date="1994">1994</year>
          <volume>13</volume>
          <fpage>1315</fpage>
          <lpage>1330</lpage>
          <pub-id pub-id-type="doi">10.1016/0896-6273(94)90418-9</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-58">
        <label>Vanden Hoek et al. (1998)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanden Hoek</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schumacker</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
          <article-title>Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes</article-title>
          <source>Journal of Biological Chemistry</source>
          <year iso-8601-date="1998">1998</year>
          <volume>273</volume>
          <fpage>18092</fpage>
          <lpage>18098</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.273.29.18092</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-59">
        <label>Wang et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>ZW</given-names>
            </name>
            <name>
              <surname>Saifee</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Nonet</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Salkoff</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>SLO-1 potassium channels control quantal content of neurotransmitter release at the C. elegans neuromuscular junction</article-title>
          <source>Neuron</source>
          <year iso-8601-date="2001">2001</year>
          <volume>32</volume>
          <fpage>867</fpage>
          <lpage>881</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00522-0</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-60">
        <label>Wang et al. (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kukreja</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Opening of <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice</article-title>
          <source>Heart and Circulatory Physiology: American Journal of Physiology</source>
          <year iso-8601-date="2004">2004</year>
          <volume>287</volume>
          <fpage>H2070</fpage>
          <lpage>H2077</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00431.2004</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-61">
        <label>Wenk &amp; McCleskey (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wenk</surname>
              <given-names>HN</given-names>
            </name>
            <name>
              <surname>McCleskey</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>A novel mouse skeletal muscle-nerve preparation and in vitro model of ischemia</article-title>
          <source>Journal of Neuroscience Methods</source>
          <year iso-8601-date="2007">2007</year>
          <volume>159</volume>
          <fpage>244</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jneumeth.2006.07.021</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-62">
        <label>Wojtovich &amp; Brookes (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojtovich</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Brookes</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial K<sub>ATP</sub> channels</article-title>
          <source>Basic Research in Cardiology</source>
          <year iso-8601-date="2009">2009</year>
          <volume>104</volume>
          <fpage>121</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="doi">10.1007/s00395-009-0001-y</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-63">
        <label>Wojtovich et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojtovich</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Sherman</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Nadtochiy</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Urciuoli</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Brookes</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Nehrke</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>SLO-2 is cytoprotective and contributes to mitochondrial potassium transport</article-title>
          <source>PLoS ONE</source>
          <year iso-8601-date="2011">2011</year>
          <volume>6</volume>
          <elocation-id>e28287</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0028287</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-64">
        <label>Wojtovich et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojtovich</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Karcz</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Nehrke</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Brookes</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>A novel mitochondrial KATP channel assay</article-title>
          <source>Circulation Research</source>
          <year iso-8601-date="2010">2010</year>
          <volume>106</volume>
          <fpage>1190</fpage>
          <lpage>1196</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.215400</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-65">
        <label>Xu et al. (2002)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Van Eyk</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Sidor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>O’Rourke</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cytoprotective role of <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>- activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channels in the cardiac inner mitochondrial membrane</article-title>
          <source>Science</source>
          <year iso-8601-date="2002">2002</year>
          <volume>298</volume>
          <fpage>1029</fpage>
          <lpage>1033</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1074360</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-66">
        <label>Yuan et al. (1994)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuan</surname>
              <given-names>BX</given-names>
            </name>
            <name>
              <surname>Ardell</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Losier</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Gross and microscopic anatomy of the canine intrinsic cardiac nervous system</article-title>
          <source>The Anatomical Record</source>
          <year iso-8601-date="1994">1994</year>
          <volume>239</volume>
          <fpage>75</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="doi">10.1002/ar.1092390109</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-67">
        <label>Zarei et al. (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zarei</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Eghbali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alioua</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Stefani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Toro</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>An endoplasmic reticulum trafficking signal prevents surface expression of a voltage- and <named-content content-type="chemical-compound">Ca<sup>2+</sup></named-content>-activated <named-content content-type="chemical-compound">K<sup>+</sup></named-content> channel splice variant</article-title>
          <source>Proceedings of the National Academy of Sciences of the United States of America</source>
          <year iso-8601-date="2004">2004</year>
          <volume>101</volume>
          <fpage>10072</fpage>
          <lpage>10077</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0302919101</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-68">
        <label>Zarei et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zarei</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Alioua</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Eghbali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stefani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Toro</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>A novel MaxiK splice variant exhibits dominant-negative properties for surface expression</article-title>
          <source>Journal of Biological Chemistry</source>
          <year iso-8601-date="2001">2001</year>
          <volume>276</volume>
          <fpage>16232</fpage>
          <lpage>16239</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M008852200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-69">
        <label>Zoratti et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoratti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De</surname>
              <given-names>MU</given-names>
            </name>
            <name>
              <surname>Gulbins</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Novel channels of the inner mitochondrial membrane</article-title>
          <source>Biochimica et Biophysica Acta</source>
          <year iso-8601-date="2009">2009</year>
          <volume>1787</volume>
          <fpage>351</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbabio.2008.11.015</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
